EPA:SAN - Sanofi Stock Price, Price Target & More

€66.17 -0.06 (-0.09 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close€66.23
Today's Range€65.87 - €66.58
52-Week Range€63.09 - €92.97
Volume6.89 million shs
Average Volume3.05 million shs
Market Capitalization$82.98 billion
P/E RatioN/A
Dividend Yield4.58%
BetaN/A

About Sanofi (EPA:SAN)

Sanofi logoSanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.

Receive SAN News and Ratings via Email

Sign-up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolEPA:SAN
CUSIPN/A
Phone+33-1-53774000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-0.27%
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares1,260,000,000

How to Become a New Pot Stock Millionaire

Sanofi (EPA:SAN) Frequently Asked Questions

What is Sanofi's stock symbol?

Sanofi trades on the EPA under the ticker symbol "SAN."

What price target have analysts set for SAN?

16 brokers have issued 12 month price objectives for Sanofi's stock. Their forecasts range from €65.00 to €95.00. On average, they anticipate Sanofi's stock price to reach €79.50 in the next twelve months. View Analyst Ratings for Sanofi.

Who are some of Sanofi's key competitors?

Who are Sanofi's key executives?

Sanofi's management team includes the folowing people:
  • Serge Weinberg, Independent Chairman of the Board (Age 66)
  • Olivier Brandicourt, Chairman of the Executive Committee, Chief Executive Officer, Director (Age 61)
  • Jerome Contamine, Executive Vice President, Chief Financial Officer, Member of the Executive Committee (Age 59)
  • Karen Marie Linehan, Executive Vice President, Legal Affairs and General Counsel; Member of the Executive Committee (Age 58)
  • Olivier Charmeil, Executive Vice President and General Manager, General Medicines & Emerging Markets; Member of the Executive Committee (Age 54)
  • Roberto Pucci, Executive Vice President, Human Resources; Member of the Executive Committee (Age 53)
  • Dominique Carouge, Executive Vice President - Head of Business Transformation Member of the Executive Committee
  • Peter Guenter, Executive Vice President, Diabetes & Cardiovascular; Member of the Executive Committee (Age 55)
  • David Loew, Executive Vice President, Sanofi Pasteur; Member of the Executive Committee
  • Philippe Luscan, Executive Vice President, Global Industrial Affairs; Member of the Executive Committee (Age 55)

Has Sanofi been receiving favorable news coverage?

Media headlines about SAN stock have trended positive this week, Accern reports. Accern identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Sanofi earned a news impact score of 0.29 on Accern's scale. They also gave news coverage about the company an impact score of 45.94 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

What is Sanofi's stock price today?

One share of SAN stock can currently be purchased for approximately €66.17.

How big of a company is Sanofi?

Sanofi has a market capitalization of $82.98 billion.

How can I contact Sanofi?

Sanofi's mailing address is 54 rue la Boetie, PARIS, 75008, France. The company can be reached via phone at +33-1-53774000.


MarketBeat Community Rating for Sanofi (SAN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  422 (Vote Outperform)
Underperform Votes:  505 (Vote Underperform)
Total Votes:  927
MarketBeat's community ratings are surveys of what our community members think about Sanofi and other stocks. Vote "Outperform" if you believe SAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SAN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Sanofi (EPA:SAN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for Sanofi in the last 12 months. Their average twelve-month price target is €79.50The high price target for SAN is €95.00 and the low price target for SAN is €65.00. There are currently 2 sell ratings, 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.132.252.272.25
Ratings Breakdown: 2 Sell Rating(s)
10 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
10 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
9 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
10 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: €79.50€81.19€87.47€88.56

Sanofi (EPA:SAN) Consensus Price Target History

Price Target History for Sanofi (EPA:SAN)

Sanofi (EPA:SAN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
4/13/2018Jefferies GroupSet Price TargetNeutral€72.00View Rating Details
4/9/2018Berenberg BankSet Price TargetNeutral€83.00View Rating Details
3/28/2018Morgan StanleySet Price TargetSell€66.00View Rating Details
3/28/2018Deutsche BankSet Price TargetBuy€88.00View Rating Details
3/13/2018Goldman SachsSet Price TargetNeutral€74.00View Rating Details
3/12/2018Kepler Capital MarketsSet Price TargetBuy€84.00View Rating Details
3/2/2018UBSSet Price TargetNeutral€68.00View Rating Details
2/20/2018BarclaysSet Price TargetSell€65.00View Rating Details
2/12/2018CfraSet Price TargetNeutral€70.00View Rating Details
2/8/2018Societe GeneraleSet Price TargetBuy€94.00View Rating Details
2/8/2018Credit Suisse GroupSet Price TargetBuy€95.00View Rating Details
2/7/2018Sanford C. BernsteinSet Price TargetNeutral€82.00View Rating Details
1/23/2018S&P GlobalSet Price TargetNeutral€78.00View Rating Details
11/2/2017JPMorgan ChaseReiterated RatingNeutralView Rating Details
10/6/2017CitigroupSet Price TargetNeutral€88.00View Rating Details
9/12/2017BNP ParibasSet Price TargetNeutral€85.00View Rating Details
12/6/2016S&P GlobalSet Price TargetNeutral€80.00View Rating Details
6/30/2016Independent ResearchSet Price TargetNeutral€77.00View Rating Details
6/9/2016Baader BankSet Price TargetNeutral€78.00View Rating Details
(Data available from 4/21/2016 forward)

Earnings

Dividends

Sanofi (EPA:SAN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Sanofi (EPA SAN) Insider Trading and Institutional Ownership History

Insider Trading History for Sanofi (EPA:SAN)

Sanofi (EPA SAN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Sanofi (EPA SAN) News Headlines

Source:
DateHeadline
UBS Reiterates €82.00 Price Target for Sanofi (SAN)UBS Reiterates €82.00 Price Target for Sanofi (SAN)
www.americanbankingnews.com - April 20 at 9:46 PM
Berkeley Lights Announces New Agreement With Sanofi for Beacon® OptoFluidic PlatformBerkeley Lights' Announces New Agreement With Sanofi for Beacon® OptoFluidic Platform
www.prnewswire.com - April 19 at 5:22 PM
WHO recommends testing before use of Sanofis dengue vaccineWHO recommends testing before use of Sanofi's dengue vaccine
finance.yahoo.com - April 19 at 5:22 PM
Form 6-K Sanofi For: Apr 18Form 6-K Sanofi For: Apr 18
www.streetinsider.com - April 18 at 5:30 PM
Sanofi Finance Chief to Leave After Almost a Decade at DrugmakerSanofi Finance Chief to Leave After Almost a Decade at Drugmaker
www.bloomberg.com - April 18 at 5:30 PM
Advent in exclusive talks to buy Sanofi generics businessAdvent in exclusive talks to buy Sanofi generics business
www.ft.com - April 17 at 5:41 PM
Sanofis CFO Contamine to retire later this yearSanofi's CFO Contamine to retire later this year
finance.yahoo.com - April 17 at 5:41 PM
[$$] Charterhouse Portfolio Company Closes Sanofi Deal[$$] Charterhouse Portfolio Company Closes Sanofi Deal
finance.yahoo.com - April 16 at 5:07 PM
Sanofis (SAN) "Neutral" Rating Reiterated at JPMorgan ChaseSanofi's (SAN) "Neutral" Rating Reiterated at JPMorgan Chase
www.americanbankingnews.com - April 15 at 11:42 PM
Sanofi (SAN) PT Set at €89.00 by Kepler Capital MarketsSanofi (SAN) PT Set at €89.00 by Kepler Capital Markets
www.americanbankingnews.com - April 15 at 8:54 PM
Advent nears deal to buy Sanofi generics businessAdvent nears deal to buy Sanofi generics business
www.ft.com - April 15 at 6:24 PM
[$$] Advent nears deal to buy Sanofi generics business[$$] Advent nears deal to buy Sanofi generics business
finance.yahoo.com - April 15 at 6:24 PM
Sanofi (SAN) PT Set at €90.00 by S&P GlobalSanofi (SAN) PT Set at €90.00 by S&P Global
www.americanbankingnews.com - April 15 at 9:23 AM
Sanofi (SAN) Given a €90.00 Price Target at JPMorgan ChaseSanofi (SAN) Given a €90.00 Price Target at JPMorgan Chase
www.americanbankingnews.com - April 14 at 6:54 PM
Sanofi (SAN) Given a €82.00 Price Target by Goldman Sachs AnalystsSanofi (SAN) Given a €82.00 Price Target by Goldman Sachs Analysts
www.americanbankingnews.com - April 14 at 3:07 PM
Sanofi (SAN) Given a €72.00 Price Target at Jefferies GroupSanofi (SAN) Given a €72.00 Price Target at Jefferies Group
www.americanbankingnews.com - April 13 at 9:38 AM
Healthcare group Sanofi to invest 350 million euros in Canada vaccine facilityHealthcare group Sanofi to invest 350 million euros in Canada vaccine facility
www.reuters.com - April 12 at 5:19 PM
Sanofi SA (SAN) Receives Consensus Recommendation of "Hold" from AnalystsSanofi SA (SAN) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 11 at 8:50 AM
Sanofi (SAN) PT Set at €81.00 by Sanofi (SAN) PT Set at €81.00 by
www.americanbankingnews.com - April 9 at 6:24 PM
Sanofi (SAN) Given a €85.00 Price Target by BNP Paribas AnalystsSanofi (SAN) Given a €85.00 Price Target by BNP Paribas Analysts
www.americanbankingnews.com - April 9 at 8:24 AM
Sanofi (SAN) Given a €83.00 Price Target by Berenberg Bank AnalystsSanofi (SAN) Given a €83.00 Price Target by Berenberg Bank Analysts
www.americanbankingnews.com - April 9 at 8:03 AM
Sanofi (SAN) Given a €81.00 Price Target at Sanofi (SAN) Given a €81.00 Price Target at
www.americanbankingnews.com - April 8 at 11:55 PM
Sanofi (SAN) Given a €85.00 Price Target at JPMorgan ChaseSanofi (SAN) Given a €85.00 Price Target at JPMorgan Chase
www.americanbankingnews.com - April 4 at 9:04 PM
Morgan Stanley Analysts Give Sanofi (SAN) a €92.00 Price TargetMorgan Stanley Analysts Give Sanofi (SAN) a €92.00 Price Target
www.americanbankingnews.com - April 4 at 7:58 PM
Biotech Stock Roundup: EDGE Falls, ALKS Down, FDA OK's AMGN Drug Label ExpansionBiotech Stock Roundup: EDGE Falls, ALKS Down, FDA OK's AMGN Drug Label Expansion
finance.yahoo.com - April 4 at 3:59 PM
Sanofis (SNY) Skin Cancer Candidate Filing Accepted in EUSanofi's (SNY) Skin Cancer Candidate Filing Accepted in EU
www.zacks.com - April 3 at 5:17 PM
Sanofi: EMA To Review Regulatory Submission For Sotagliflozin - Quick FactsSanofi: EMA To Review Regulatory Submission For Sotagliflozin - Quick Facts
www.nasdaq.com - March 29 at 5:14 PM
Sanofi (SAN) Given a €88.00 Price Target at Deutsche BankSanofi (SAN) Given a €88.00 Price Target at Deutsche Bank
www.americanbankingnews.com - March 28 at 10:27 AM
Sanofi (SAN) Given a €66.00 Price Target by Morgan Stanley AnalystsSanofi (SAN) Given a €66.00 Price Target by Morgan Stanley Analysts
www.americanbankingnews.com - March 28 at 9:39 AM
Sanofi (SAN) PT Set at €82.00 by Goldman SachsSanofi (SAN) PT Set at €82.00 by Goldman Sachs
www.americanbankingnews.com - March 26 at 9:53 PM
Sanofi (SAN) Given a €65.00 Price Target by Barclays AnalystsSanofi (SAN) Given a €65.00 Price Target by Barclays Analysts
www.americanbankingnews.com - March 26 at 9:52 PM
Sanofi (SAN) Given a €100.00 Price Target at Societe GeneraleSanofi (SAN) Given a €100.00 Price Target at Societe Generale
www.americanbankingnews.com - March 26 at 8:46 PM
Sanofi (SAN) Given a €93.00 Price Target at Deutsche BankSanofi (SAN) Given a €93.00 Price Target at Deutsche Bank
www.americanbankingnews.com - March 26 at 4:18 PM
Sanofi (SAN) Given a €82.00 Price Target by Sanford C. Bernstein AnalystsSanofi (SAN) Given a €82.00 Price Target by Sanford C. Bernstein Analysts
www.americanbankingnews.com - March 25 at 8:16 AM
Sanofi (SAN) PT Set at €97.00 by Berenberg BankSanofi (SAN) PT Set at €97.00 by Berenberg Bank
www.americanbankingnews.com - March 25 at 8:16 AM
[$$] Nordic Capital bows out of Sanofi EU generics unit auction[$$] Nordic Capital bows out of Sanofi EU generics unit auction
finance.yahoo.com - March 21 at 5:23 PM
Sanofi (SAN) PT Set at €74.00 by Goldman SachsSanofi (SAN) PT Set at €74.00 by Goldman Sachs
www.americanbankingnews.com - March 18 at 11:52 AM
Sanofi SA (SAN) Given Average Recommendation of "Hold" by AnalystsSanofi SA (SAN) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - March 17 at 8:43 AM
The Zacks Analyst Blog Highlights: AT&T, Goldman Sachs, Sanofi, General Mills and DiscoveryThe Zacks Analyst Blog Highlights: AT&T, Goldman Sachs, Sanofi, General Mills and Discovery
finance.yahoo.com - March 16 at 6:12 PM
Top Research Report for AT&T, Goldman Sachs & SanofiTop Research Report for AT&T, Goldman Sachs & Sanofi
finance.yahoo.com - March 15 at 5:51 PM
An Intrinsic Calculation For Sanofi (EPA:SAN) Shows It’s 40% UndervaluedAn Intrinsic Calculation For Sanofi (EPA:SAN) Shows It’s 40% Undervalued
finance.yahoo.com - March 15 at 5:51 PM
Bull of the Day: Regeneron (REGN)Bull of the Day: Regeneron (REGN)
finance.yahoo.com - March 14 at 9:02 AM
Sanofi (SAN) Given a €84.00 Price Target by Kepler Capital Markets AnalystsSanofi (SAN) Given a €84.00 Price Target by Kepler Capital Markets Analysts
www.americanbankingnews.com - March 12 at 2:03 PM
Regeneron Looks To Capitalize On New Praluent DataRegeneron Looks To Capitalize On New Praluent Data
seekingalpha.com - March 12 at 11:34 AM
Regeneron, Sanofi to cut cholesterol drug priceRegeneron, Sanofi to cut cholesterol drug price
www.marketwatch.com - March 10 at 6:08 PM
Canopy And Alcaliber: Combining Cannabis And MorphineCanopy And Alcaliber: Combining Cannabis And Morphine
seekingalpha.com - March 9 at 6:27 PM
Merck Doubles Down on Debt Reduction - Wall Street Journal (blog)Merck Doubles Down on Debt Reduction - Wall Street Journal (blog)
www.wsj.com - March 9 at 8:45 AM
Sanofi Clears a Hurdle in Bribery Probe - Wall Street Journal (blog)Sanofi Clears a Hurdle in Bribery Probe - Wall Street Journal (blog)
blogs.wsj.com - March 8 at 6:17 PM
Sanofis Board of Directors Proposes Appointment of Emmanuel ... - NasdaqSanofi's Board of Directors Proposes Appointment of Emmanuel ... - Nasdaq
www.nasdaq.com - March 8 at 8:44 AM
Sanofis Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent DirectorSanofi's Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director
finance.yahoo.com - March 6 at 5:27 PM

SEC Filings

Sanofi (EPA:SAN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Sanofi (EPA SAN) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.